Maple Drug Substances And Products Private Limited - Company Profile

It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Maple Drug Substances And Products Private Limited

Maple Drug Substances And Products Private Limited, a active private limited company, was established on 14 September 2020 in Hyderabad, Telangana, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U33110TG2020PTC143892. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Harsha Vardhan Nandepu (Director), Hardev Nandepu (Director), Venkateswara Rao Nandepu (Director). It holds ₹95.00 Cr open charges and ₹60.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 7-1-638 To 643, 643/1, Flat No. 302, Beside Esi Hospital, Erragadda,, Hyderabad, Telangana, 500038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110TG2020PTC143892

  • Registration Number

    143892

  • Incorporation Date

    14 September 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 95.00 Cr
  • Satisfied Charges ₹ 60.00 Cr
  • Revenue Growth **** %
  • Profit Growth **** 30.90%
  • Ebitda **** 50.93%
  • Net Worth -4.69%
  • Total Assets -1.01%
Company report

Maple Drug Substances And Products Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Maple Drug Substances And Products Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Maple Drug Substances And Products Private Limited?
Current Directors
Name Designation Appointment Date Status
Harsha Vardhan Nandepu Director 14 Sep 2020 Current
Hardev Nandepu Director 14 Sep 2020 Current
Venkateswara Rao Nandepu Director 14 Sep 2020 Current
Veera Venkata Rama Vijayalakshmi Nandepu Director 14 Sep 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maple Drug Substances And Products.

Maple Drug Substances And Products Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.9% increase in profit. The company's net worth dipped by a decrease of 4.69%.

Maple Drug Substances And Products revenue growth over time
Maple Drug Substances And Products profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -1.01%
*******
*******
*******
*******
Profit or Loss
*******
 30.90%
*******
*******
*******
*******
Net Worth
*******
 -4.69%
*******
*******
*******
*******
EBITDA
*******
 50.93%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maple Drug Substances And Products?

Unlock access to Maple Drug Substances And Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹950,000,000.00

Satisfied Charges

₹600,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 95.00 Cr
Latest Charge Details
Date Lender Amount Status
08 Jan 2026 Others ₹95.00 Cr Open
10 Dec 2024 Others ₹60.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Maple Drug Substances And Products?

Maple Drug Substances And Products has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maple Drug Substances And Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maple Drug Substances And Products's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maple Drug Substances And Products
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others amounted to Rs. 950.00 M with Charge ID 101225334 was registered on 08 Jan 2026. was documented.

  • Charges

    The activity A charge registered on 10 Dec 2024 via Charge ID 101020521 with Others was fully satisfied on 25 Nov 2025. was completed.

  • Annual General Meeting

    Progress on Maple Drug Substances And Products Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Maple Drug Substances And Products Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 600.00 M with Charge ID 101020521 was registered on 10 Dec 2024. was completed.

  • Director Appointment

    Harsha Vardhan Nandepu was appointed as a Director was appointed as a Director on 14 Sep 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maple Drug Substances And Products Private Limited?

The CIN of Maple Drug Substances And Products Private Limited is U33110TG2020PTC143892.

Where is Maple Drug Substances And Products Private Limited headquartered?

Maple Drug Substances And Products Private Limited is headquartered at 7-1-638 To 643, 643/1, Flat No. 302, Beside Esi Hospital, Erragadda,, Hyderabad, Telangana, 500038.

When was Maple Drug Substances And Products Private Limited incorporated?

Maple Drug Substances And Products Private Limited was incorporated on 14 September 2020.

Who are the current directors of Maple Drug Substances And Products Private Limited?

The current directors of Maple Drug Substances And Products Private Limited are

What is the primary industry of Maple Drug Substances And Products Private Limited?

The primary industry of Maple Drug Substances And Products Private Limited is Healthcare.

Is Maple Drug Substances And Products Private Limited a listed company?

Maple Drug Substances And Products Private Limited is unlisted.

What is the capital structure of Maple Drug Substances And Products Private Limited?

The authorized capital of Maple Drug Substances And Products Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available